Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges
Roots Analysis
NOVEMBER 3, 2023
Several trials focused on evaluation of such drugs were discontinued in the past. Several factors have contributed to the failure of NAMPT inhibitors in clinical trials, including poor pharmacokinetic properties, limited efficacy, and toxicity issues.
40 
Let's personalize your content